Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders
Targeted immune-modulating treatment with biological agents has revolutionized the management of immune-mediated inflammatory diseases, including rheumatologic conditions. The efficacy and tolerability of biological agents, from the initial tumour necrosis factor (TNF)-α inhibitors to the new anti-c...
Main Authors: | Simone Garcovich, Clara De Simone, Giovanni Genovese, Emilio Berti, Massimo Cugno, Angelo Valerio Marzano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00282/full |
Similar Items
-
Systematic review of TNFα-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients
by: Rishab Revankar, et al.
Published: (2023-12-01) -
Corrigendum: Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement
by: Eleonora Quattri, et al.
Published: (2022-12-01) -
Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement
by: Eleonora Quattri, et al.
Published: (2022-09-01) -
Successful Treatment of Paradoxical Psoriasis with IL 17 Inhibition: Case Reports
by: Gamze Gül Güleç, et al.
Published: (2020-02-01) -
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
by: Zuzana Jiraskova Zakostelska, et al.
Published: (2023-03-01)